| 2P4 | Name: | (5R)-N-benzyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)cyclopent-1-ene-1-carboxamide | Formula: | C20 H26 N2 O4 | SMILES: | O=C(N1C(C(O)CO)CCC1)C3C(C(=O)NCc2ccccc2)=CCC3 | InChi: | InChI=1S/C20H26N2O4/c23-13-18(24)17-10-5-11-22(17)20(26)16-9-4-8-15(16)19(25)21-12-14-6-2-1-3-7-14/h1-3,6-8,16-18,23-24H,4-5,9-13H2,(H,21,25)/t16-,17+,18+/m1/s1 | Definition date: | 2012-03-15 | Last modified: | 2024-09-27 | Identifier: | (5R)-N-benzyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)cyclopent-1-ene-1-carboxamide |
|
| OMG | Name: | O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE | Formula: | C11 H16 N5 O8 P | SMILES: | O=C1c2ncn(c2N=C(N)N1)C3OC(C(O)C3OC)COP(=O)(O)O | InChi: | InChI=1S/C11H16N5O8P/c1-22-7-6(17)4(2-23-25(19,20)21)24-10(7)16-3-13-5-8(16)14-11(12)15-9(5)18/h3-4,6-7,10,17H,2H2,1H3,(H2,19,20,21)(H3,12,14,15,18)/t4-,6-,7-,10-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2'-O-methylguanosine 5'-(dihydrogen phosphate) |
|
| 2P6 | Name: | (2S)-1-[1-(4-phenylbutanoyl)-L-prolyl]pyrrolidine-2-carbonitrile | Formula: | C20 H25 N3 O2 | SMILES: | O=C(N1C(C#N)CCC1)C3N(C(=O)CCCc2ccccc2)CCC3 | InChi: | InChI=1S/C20H25N3O2/c21-15-17-10-5-13-22(17)20(25)18-11-6-14-23(18)19(24)12-4-9-16-7-2-1-3-8-16/h1-3,7-8,17-18H,4-6,9-14H2/t17-,18-/m0/s1 | Definition date: | 2012-03-15 | Last modified: | 2024-09-27 | Identifier: | (2S)-1-[1-(4-phenylbutanoyl)-L-prolyl]pyrrolidine-2-carbonitrile |
|
| OMH | Name: | O-[(S)-hydroxy(methoxy)phosphoryl]-L-serine | Formula: | C4 H10 N O6 P | SMILES: | O=P(O)(OC)OCC(N)C(=O)O | InChi: | InChI=1S/C4H10NO6P/c1-10-12(8,9)11-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)(H,8,9)/t3-/m0/s1 | Definition date: | 2009-02-27 | Last modified: | 2024-09-27 | Identifier: | O-[(S)-hydroxy(methoxy)phosphoryl]-L-serine |
|
| 2P8 | Name: | (2S)-N-benzyl-2-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidine-1-carboxamide | Formula: | C19 H27 N3 O4 | SMILES: | O=C(N1C(C(O)CO)CCC1)C3N(C(=O)NCc2ccccc2)CCC3 | InChi: | InChI=1S/C19H27N3O4/c23-13-17(24)15-8-4-10-21(15)18(25)16-9-5-11-22(16)19(26)20-12-14-6-2-1-3-7-14/h1-3,6-7,15-17,23-24H,4-5,8-13H2,(H,20,26)/t15-,16-,17-/m0/s1 | Definition date: | 2012-03-15 | Last modified: | 2024-09-27 | Identifier: | (2S)-N-benzyl-2-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidine-1-carboxamide |
|
| OML | Name: | (1R,2S,3R,4R)-5-fluoro-6-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol | Formula: | C7 H11 F O5 | SMILES: | OC1C(CO)=C(F)C(O)C(O)C1O | InChi: | InChI=1S/C7H11FO5/c8-3-2(1-9)4(10)6(12)7(13)5(3)11/h4-7,9-13H,1H2/t4-,5+,6+,7+/m1/s1 | Synonyms: | C5a-fluoro-valienide | Definition date: | 2022-05-12 | Last modified: | 2024-09-27 | Release date: | 2023-04-05 | Identifier: | (1R,2S,3R,4R)-5-fluoro-6-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol |
|
| 2PB | Name: | 2-[(DIOXIDOPHOSPHINO)OXY]BENZOATE | Formula: | C7 H5 O5 P | SMILES: | O=P([O-])Oc1ccccc1C([O-])=O | InChi: | InChI=1S/C7H7O5P/c8-7(9)5-3-1-2-4-6(5)12-13(10)11/h1-4,13H,(H,8,9)(H,10,11)/p-2 | Definition date: | 2004-03-26 | Last modified: | 2024-09-27 | Identifier: | 2-[(dioxidophosphanyl)oxy]benzoate |
|
| OMT | Name: | S-DIOXYMETHIONINE | Formula: | C5 H11 N O4 S | SMILES: | O=S(=O)(C)CCC(C(=O)O)N | InChi: | InChI=1S/C5H11NO4S/c1-11(9,10)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-4-(methylsulfonyl)butanoic acid |
|
| OMU | Name: | O2'-METHYLURIDINE 5'-MONOPHOSPHATE | Formula: | C10 H15 N2 O9 P | SMILES: | O=C1NC(=O)N(C=C1)C2OC(C(O)C2OC)COP(=O)(O)O | InChi: | InChI=1S/C10H15N2O9P/c1-19-8-7(14)5(4-20-22(16,17)18)21-9(8)12-3-2-6(13)11-10(12)15/h2-3,5,7-9,14H,4H2,1H3,(H,11,13,15)(H2,16,17,18)/t5-,7-,8-,9-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2'-O-methyluridine 5'-(dihydrogen phosphate) |
|
| OMX | Name: | (betaR)-beta-hydroxy-L-Tyrosine | Formula: | C9 H11 N O4 | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8+/m0/s1 | Definition date: | 2010-08-10 | Last modified: | 2024-09-27 | Identifier: | (betaR)-beta-hydroxy-L-tyrosine |
|
| OMY | Name: | (betaR)-3-chloro-beta-hydroxy-L-tyrosine | Formula: | C9 H10 Cl N O4 | SMILES: | Clc1cc(ccc1O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO4/c10-5-3-4(1-2-6(5)12)8(13)7(11)9(14)15/h1-3,7-8,12-13H,11H2,(H,14,15)/t7-,8+/m0/s1 | Definition date: | 2009-03-27 | Last modified: | 2024-09-27 | Identifier: | (betaR)-3-chloro-beta-hydroxy-L-tyrosine |
|
| OMZ | Name: | (betaR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE | Formula: | C9 H10 Cl N O4 | SMILES: | Clc1cc(ccc1O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO4/c10-5-3-4(1-2-6(5)12)8(13)7(11)9(14)15/h1-3,7-8,12-13H,11H2,(H,14,15)/t7-,8-/m1/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | (betaR)-3-chloro-beta-hydroxy-D-tyrosine |
|
| 2PP | Name: | 2-PROPYL-PENTANOIC ACID | Formula: | C8 H16 O2 | SMILES: | O=C(O)C(CCC)CCC | InChi: | InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-propylpentanoic acid |
|
| ONH | Name: | N~5~-hydroxy-L-ornithine | Formula: | C5 H12 N2 O3 | SMILES: | O=C(O)C(N)CCCNO | InChi: | InChI=1S/C5H12N2O3/c6-4(5(8)9)2-1-3-7-10/h4,7,10H,1-3,6H2,(H,8,9)/t4-/m0/s1 | Definition date: | 2011-06-02 | Last modified: | 2024-09-27 | Identifier: | N~5~-hydroxy-L-ornithine |
|
| 2Q7 | Name: | N-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide | Formula: | C27 H35 F2 N11 O4 | SMILES: | C=CC(=O)N1CCC(CC1)C(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)c1cnc(N)nc1C(F)F)N1CCOCC1 | InChi: | InChI=1S/C27H35F2N11O4/c1-2-19(41)37-5-3-17(4-6-37)24(43)31-16-20(42)38-7-9-39(10-8-38)26-34-23(18-15-32-25(30)33-21(18)22(28)29)35-27(36-26)40-11-13-44-14-12-40/h2,15,17,22H,1,3-14,16H2,(H,31,43)(H2,30,32,33) | Definition date: | 2021-06-30 | Last modified: | 2024-09-27 | Release date: | 2022-04-06 | Identifier: | N-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide |
|
| ONK | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H50 N4 O5 | SMILES: | O=C(NC(CC(C)C)C(O)C(=C)C)C(NC(=O)C(NC(=O)CCCCC)C(C)C)CCC(=O)N(C)C | InChi: | InChI=1S/C27H50N4O5/c1-10-11-12-13-22(32)30-24(18(4)5)27(36)28-20(14-15-23(33)31(8)9)26(35)29-21(16-17(2)3)25(34)19(6)7/h17-18,20-21,24-25,34H,6,10-16H2,1-5,7-9H3,(H,28,36)(H,29,35)(H,30,32)/t20-,21-,24-,25-/m0/s1 | Synonyms: | vinylketone carmaphycin analogue VNK1, single bound form | Definition date: | 2012-11-01 | Last modified: | 2024-09-27 | Release date: | 2014-01-29 | Identifier: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide |
|
| ONL | Name: | 5-OXO-L-NORLEUCINE | Formula: | C6 H11 N O3 | SMILES: | O=C(CCC(N)C(=O)O)C | InChi: | InChI=1S/C6H11NO3/c1-4(8)2-3-5(7)6(9)10/h5H,2-3,7H2,1H3,(H,9,10)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 5-oxo-L-norleucine |
|
| OO1 | Name: | (4-methylphenyl)carbamic acid | Formula: | C8 H9 N O2 | SMILES: | C(O)(=O)Nc1ccc(cc1)C | InChi: | InChI=1S/C8H9NO2/c1-6-2-4-7(5-3-6)9-8(10)11/h2-5,9H,1H3,(H,10,11) | Definition date: | 2019-07-01 | Last modified: | 2024-09-27 | Release date: | 2019-11-06 | Identifier: | (4-methylphenyl)carbamic acid |
|
| 2QY | Name: | (2Z)-3-(4-hydroxyphenyl)-2-(methylamino)prop-2-enoic acid | Formula: | C10 H11 N O3 | SMILES: | O=C(O)/C(=C/c1ccc(O)cc1)NC | InChi: | InChI=1S/C10H11NO3/c1-11-9(10(13)14)6-7-2-4-8(12)5-3-7/h2-6,11-12H,1H3,(H,13,14)/b9-6- | Definition date: | 2014-01-09 | Last modified: | 2024-09-27 | Release date: | 2014-04-02 | Identifier: | (2Z)-3-(4-hydroxyphenyl)-2-(methylamino)prop-2-enoic acid |
|
| 2QZ | Name: | N,N-dimethyl-L-threonine | Formula: | C6 H13 N O3 | SMILES: | O=C(O)C(N(C)C)C(O)C | InChi: | InChI=1S/C6H13NO3/c1-4(8)5(6(9)10)7(2)3/h4-5,8H,1-3H3,(H,9,10)/t4-,5+/m1/s1 | Definition date: | 2014-01-10 | Last modified: | 2024-09-27 | Release date: | 2014-04-02 | Identifier: | N,N-dimethyl-L-threonine |
|
| 2R1 | Name: | (2E)-2-amino-4-hydroxy-3-[(2R)-oxiran-2-yl]but-2-enoic acid | Formula: | C6 H9 N O4 | SMILES: | O=C(O)/C(N)=C(/CO)C1OC1 | InChi: | InChI=1S/C6H9NO4/c7-5(6(9)10)3(1-8)4-2-11-4/h4,8H,1-2,7H2,(H,9,10)/b5-3+/t4-/m0/s1 | Definition date: | 2014-01-10 | Last modified: | 2024-09-27 | Release date: | 2014-04-02 | Identifier: | (2E)-2-amino-4-hydroxy-3-[(2R)-oxiran-2-yl]but-2-enoic acid |
|
| 2R3 | Name: | (betaR)-beta-hydroxy-O-methyl-L-tyrosine | Formula: | C10 H13 N O4 | SMILES: | O=C(O)C(N)C(O)c1ccc(OC)cc1 | InChi: | InChI=1S/C10H13NO4/c1-15-7-4-2-6(3-5-7)9(12)8(11)10(13)14/h2-5,8-9,12H,11H2,1H3,(H,13,14)/t8-,9+/m0/s1 | Definition date: | 2014-01-10 | Last modified: | 2024-09-27 | Release date: | 2014-04-02 | Identifier: | (betaR)-beta-hydroxy-O-methyl-L-tyrosine |
|
| OOG | Name: | 2-OXOADIPIC ACID | Formula: | C6 H8 O5 | SMILES: | O=C(C(=O)O)CCCC(=O)O | InChi: | InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11) | Definition date: | 2015-01-21 | Last modified: | 2024-09-27 | Release date: | 2015-01-28 | Identifier: | 2-oxohexanedioic acid |
|
| OOL | Name: | (E)-1-(4,6-dimethoxypyrimidin-2-yl)methanimine | Formula: | C7 H9 N3 O2 | SMILES: | N=Cc1nc(OC)cc(OC)n1 | InChi: | InChI=1S/C7H9N3O2/c1-11-6-3-7(12-2)10-5(4-8)9-6/h3-4,8H,1-2H3/b8-4+ | Definition date: | 2023-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | (E)-1-(4,6-dimethoxypyrimidin-2-yl)methanimine |
|
| 2RA | Name: | 3-amino-D-alanine | Formula: | C3 H8 N2 O2 | SMILES: | O=C(O)C(N)CN | InChi: | InChI=1S/C3H8N2O2/c4-1-2(5)3(6)7/h2H,1,4-5H2,(H,6,7)/t2-/m1/s1 | Synonyms: | diaminopropanoic acid | Definition date: | 2010-09-27 | Last modified: | 2024-09-27 | Identifier: | 3-amino-D-alanine |
|